Search Results 2261-2270 of 13641 for monoclonal antibody
For various rare immunobullous diseases, detection of a circulating autoantibody is necessary for accurate diagnosis. As a CLIA requirement, every clinical ...
* Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects). A Study To ...
Both chimeric antigen receptor (CAR)-T cell and bispecific antibody (BsAb) as T cell-directed therapies have yielded impressive clinical responses in people ...
Patients who are newly diagnosed with lymphoma are offered a combination of chemotherapy and antibody-based treatments. But for those who do not respond to ...
... antibodies. "Cilta-cel is made from patient's own T cells that have been genetically engineered and administered as a single dose infusion," says Dr. Lin ...
“Our randomized study showed that the addition of an antibody drug conjugate, brentuximab vedotin, to standard chemotherapy in patients with advanced stage ...
Genetic differences were found between people with robust protective antibodies and those with lower immunity from smallpox. Dr. Poland says this ...
quantitative IgM monoclonal protein > 1,000 mg/dL. ANC ≥ 1000/uL; Hgb ≥ 9 g/dl; PLT ≥ 75,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if ...
Has previously received natalizumab, efalizumab, adalimumab, AMG-181, anti-mucosal addressin cell adhesion molecule-1 antibodies, or rituximab. Has ...
Completion of, if applicable, radiotherapy, chemotherapy, antibodies and immunoconjugates including brentuximab vedotin and/or another investigational drug ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.